Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
Clinical trial NCT00078039 · COMPLETED
Trial details
- NCT number
- NCT00078039
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.